UK markets open in 2 hours 11 minutes

Mereo BioPharma Group plc (MREO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.6100+0.0100 (+0.62%)
At close: 04:00PM EST
1.6000 -0.01 (-0.62%)
After hours: 04:04PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
36,464
0
0
0
0
Cost of revenue
34,484
16,347
23,608
22,704
31,321
Gross profit
1,980
-16,347
-23,608
-22,704
-34,607
Operating expenses
Research development
-
-
-
22,704
31,321
Selling general and administrative
21,683
21,222
15,909
12,505
683.668
Total operating expenses
23,062
21,222
15,909
12,505
13,982
Operating income or loss
-21,082
-37,569
-39,517
-35,208
-45,304
Interest expense
5,428
6,383
4,827
3,055
497.173
Total other income/expenses net
-2,923
-122,542
1,974
-65.766
-1,723
Income before tax
-29,445
-166,450
-41,118
-37,306
-46,951
Income tax expense
-2,524
-2,822
-6,274
-5,277
-8,152
Income from continuing operations
-26,921
-163,628
-34,844
-32,029
-38,799
Net income
-26,921
-163,628
-34,844
-32,029
-38,799
Net income available to common shareholders
-26,921
-163,628
-34,844
-32,029
-38,799
Basic EPS
-
-
-1.95
-2.25
-2.80
Diluted EPS
-
-
-1.95
-2.25
-2.80
Basic average shares
-
-
17,885
14,229
13,802
Diluted average shares
-
-
17,885
14,229
13,802
EBITDA
-
-158,468
-34,714
-34,213
-46,418